Literature DB >> 31048796

Novel drug targets in 2018.

Oleg Ursu, Meir Glick, Tudor Oprea.   

Abstract

Year:  2019        PMID: 31048796     DOI: 10.1038/d41573-019-00052-5

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

Review 1.  Exploring the dark genome: implications for precision medicine.

Authors:  Tudor I Oprea
Journal:  Mamm Genome       Date:  2019-07-04       Impact factor: 2.957

2.  The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer.

Authors:  Derek Essegian; Rimpi Khurana; Vasileios Stathias; Stephan C Schürer
Journal:  Cell Rep Med       Date:  2020-10-20

Review 3.  Benzothiazoles as potential antiviral agents.

Authors:  Yahya I Asiri; Abdulrhman Alsayari; Abdullatif B Muhsinah; Yahia N Mabkhot; Mohd Z Hassan
Journal:  J Pharm Pharmacol       Date:  2020-07-24       Impact factor: 3.765

4.  Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke.

Authors:  Lingyan Chen; James E Peters; Bram Prins; Elodie Persyn; Matthew Traylor; Praveen Surendran; Savita Karthikeyan; Ekaterina Yonova-Doing; Emanuele Di Angelantonio; David J Roberts; Nicholas A Watkins; Willem H Ouwehand; John Danesh; Cathryn M Lewis; Paola G Bronson; Hugh S Markus; Stephen Burgess; Adam S Butterworth; Joanna M M Howson
Journal:  Nat Commun       Date:  2022-10-17       Impact factor: 17.694

5.  TCRD and Pharos 2021: mining the human proteome for disease biology.

Authors:  Timothy K Sheils; Stephen L Mathias; Keith J Kelleher; Vishal B Siramshetty; Dac-Trung Nguyen; Cristian G Bologa; Lars Juhl Jensen; Dušica Vidović; Amar Koleti; Stephan C Schürer; Anna Waller; Jeremy J Yang; Jayme Holmes; Giovanni Bocci; Noel Southall; Poorva Dharkar; Ewy Mathé; Anton Simeonov; Tudor I Oprea
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.